Dr. Charles Evans serves as the Senior Vice President of Pharmaceutical Development at MedPharm, where he has dedicated over 15 years to advancing the company’s formulation development strategies. His extensive expertise spans the successful creation of commercial products across various delivery systems, including topical, inhalation, and transdermal formulations. Dr. Evans was instrumental in developing MedPharm’s proprietary MedSpray® technology, which is currently licensed to enhance client product performance. He earned his Ph.D. from the University of Hertfordshire, focusing his research on a novel dynamic spray formulation for treating Athlete’s foot.
In his current role, Dr. Evans oversees MedPharm’s product development efforts, ensuring the delivery of robust and effective pharmaceutical solutions. His leadership has been pivotal in refining MedPharm’s rigorous approach to formulation development, contributing significantly to the company’s reputation as a leader in topical and transdermal product design and development services.
Dr. Evans has also shared his insights on industry trends, such as the advantages of nasal drug delivery systems, emphasizing their potential to enhance patient-centered development strategies.
His commitment to innovation and excellence continues to drive MedPharm’s success in delivering cutting-edge pharmaceutical solutions.